Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Market Whispers
Tax Planning
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund

| More

Oil India - Offer For Sale - Microsec

Posted On: 2013-01-31 21:16:43

Empowered Group of Ministers (EGOM) approved Oil India's divestment plan by selling a 10percent(%) stake through Offer for sale (OFS) on February 01,2013. The GoI is planning to raise around INR2500-3000crores as a part of its budgetary divestment plan of total INR30000crores. This 10% stake sale will bring down the government's holdings in the company to 68.43percent(%) from the earlier 78.43percent(%). 6.01crores of shares will be offered at a floor price of INR510/share to raise around INR3000crores.

We believe this OFS may provide a better platform for the investors to invest on the scrip as Oil India is a fundamentally sound company with virtually no debt in their books. Moreover it is a cash rich company with more than ~INR10000crores as per the last balance sheet and the government's move to deregulate diesel prices will act as a boon to the company as OIL India is one of those upstream company that has to bear the subsidy burden. With the gradual deregulation in diesel prices and capping of subsidized LPG to 9 per household will curb the underrecoveries and eventually the subsidy burden. Decline in subsidy burden may result in the improvement in the net realization ($/bbl) which is likely to impact the Oil India's earnings in a positive way. Besides the company probably allocate the cash (that has saved from relaxation in subsidy burden) in some productive manner.

On the valuation grounds Oil India possess a healthy Return on Equity (RoE) of ~20% which is expected to continue and if the deregulation of diesel prices is fully implemented we can expect a re-rating of their valuation multiple.

The government states that they are expecting more of overseas investors for the Oil India's OFS. 25% of the stake will be allotted to the AMCs as per the SEBI Mutual Fund Act.

If there is any change in policy from the government's end may count as the only apprehension regarding the stock.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Views on TVS Motors 1QFY2016 Results: Angel Broking
India Infrastructure - Reforms signal all systems go! - Religare
Views on Lupin - Updates: Angel Broking
Views on Wipro 1QFY2016 Results: Angel Broking
View on Lupin Limited 1QFY2016 Results: Angel Broking
Views on Bajaj Auto 1QFY2016 Results: Angel Broking
Views on Ceat Ltd 1QFY2016 Results: Angel Broking
View on Sanofi India 2QCY2015 Results: Angel Broking
Views on Eicher Motors 2QCY2015 Results: Angel Broking
Views on HDFC Bank 1QFY2016 Results: Angel Broking
Views on Sun Pharmaceuticals Update: Angel Broking
Views on Infosys 1QFY2016 Results: Angel Broking
Views on Rane Brake Liners 1QFY2016 Results: Angel Broking
Views on Ultratech Cement 1QFY2015 Results: Angel Broking
Views on Lupin - get USFDA approval for Prandimet: Angel Broking
Views on NPPA - Update: Angel Broking
BUY Unichem Laboratories: Anand Rathi Research
Views on Hindustan Media Ventures Ltd 1QFY2016 Results: Angel Broking
Views on Sun Pharmaceuticals: Angel Broking
Views on Dr. Reddys announces the Launch of Memantine Hydrochloride Tablets: Angel Broking
JM Financial buy reccomendation on Shriram Transport Finance Company
Styrolution ABS (India) - Company Update - Angel Broking
KNR Constructions - Road laid for a sustainable drive - Angel Broking
Views on Wipro Digital to Enhance Digital Transformation Capability with Designit: Angel Broking
Views on TCS 1QFY2016 Results: Angel Broking
Views on Tech Mahindra inks strategic pact with PNMsoft: Angel Broking
Views on Infosys signs multi-year agreement with Deutsche Bank: Angel Broking
India Auto sales in June 2015 - Microsec
Alembic Pharma, Lupin & Sun Pharma get approval for Desvenlafaxine Succinate: Angel Broking
Views on Zydus Cadila receives Market Authorisation (MA) from USFDA for Morphine Sulfate ER Tablets: Angel Broking
India Economy Core infrastructure - Sharp recovery in core, may not be sustainable - Anand Rathi Financial Services
Views on Tech Mahindra - Investor Update: Angel Broking
BUY Welspun India - Anand Rathi Retail Research
BUY Persistent Systems - Anand Rathi Research
Alembic Pharmaceuticals - Gets tentative approval from USFDA for Celecoxib: Angel Broking
Views on Tech Mahindra and Circle Health sign 10-year strategic deal: Angel Broking
World financial fears keep Asia firms in holding pattern
India Technology - Tapering growth and volatility weighing on valuations: Anand Rathi Financial Services
Views on Lupin - Board of Directors approve the Fund Raising: Angel Broking
Views on NPPA update: Angel Broking
Views on Aurobindo Pharma gets USFDA approval for Azithromycin: Angel Broking
Balance of Payments - FDI inflows at all-time high: Anand Rathi Financial Sercices
Angel Broking views on US opens probe against TCS, Infosys for H1-B visa violations
Views on SPARC Licenses XelprosTM (Latanoprost BAK-free) to Sun Pharma - Angel Broking
Views on Infosys Update: Angel Broking
Cipla - 4QFY2015 Result Update - Angel Broking
Action Construction Equipment - 4QFY2015 Result Update - Angel Broking
Views on Sun Pharma and AstraZeneca enter into distribution agreement for ticagrelor in India: Angel Broking
India Cements - 4QFY2015 Result Update - Angel Broking
Coal India - 4QFY2015 Result Update - Angel Broking

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2014